Why Is Intuniv So Hard to Find? [Explained for 2026]

If you've walked into a pharmacy recently and been told Intuniv is out of stock — or found yourself calling around with no luck — you're not alone. Despite being a non-stimulant ADHD medication that isn't subject to the DEA quotas that restrict stimulant supply, Intuniv (guanfacine extended-release) can still be frustratingly hard to track down at any given pharmacy on any given day.

Here's what's really going on — and what you can do about it.

Is Intuniv Currently in Shortage?

As of 2026, Intuniv (guanfacine ER) is not listed on the FDA's official Drug Shortage database for the U.S. market. This is notably different from many stimulant ADHD medications like Adderall and Ritalin, which have been on the FDA shortage list since 2022. Because Intuniv is not a controlled substance and is not subject to DEA production quotas, the structural supply bottlenecks that have plagued stimulant ADHD drugs do not apply here.

However, there was a significant shortage of Intuniv in the United Kingdom and other international markets in 2023. Takeda, the brand manufacturer at the time, temporarily suspended new patient starts and warned of supply disruptions across multiple strengths (1 mg, 2 mg, 3 mg, and 4 mg). That UK shortage has largely resolved since then, but it's worth knowing this history if you see confusing information online.

So Why Can't I Find Intuniv at My Pharmacy?

Even when a medication is not in a formal national shortage, individual pharmacies can still run out. Here are the most common reasons:

• Generic market fragmentation. Multiple generic manufacturers produce guanfacine ER, but not every pharmacy stocks every manufacturer's version. If your insurance requires a specific generic and that one is backordered, you may hit a wall even when other generics are available at a different pharmacy.
• Specific strength variations. Certain dose strengths may be harder to find than others depending on your region and which manufacturers are supplying local distributors. The 3 mg and 4 mg strengths tend to have less consistent availability than 1 mg and 2 mg at some pharmacies.
• Regional distribution gaps. A single pharmacy chain may be well-stocked nationally but run low in specific locations. Independent pharmacies sometimes source from different wholesalers than large chains, giving them different — sometimes better — access to specific medications.
• Brand vs. generic insurance mismatch. If your insurance covers only one version (brand or a specific generic) and your local pharmacy doesn't stock it, you may face delays even though the medication is generally available.

Why Intuniv Is a Target of Increased Demand in 2026

One important factor driving Intuniv demand is the ongoing stimulant shortage. As of early 2026, the FDA still lists amphetamine mixed salts (Adderall) and methylphenidate formulations in shortage. Pediatricians, psychiatrists, and PCPs have been actively switching patients to non-stimulant alternatives like Intuniv — both for patients who can't tolerate stimulants and for those who simply can't fill their stimulant prescriptions.

Intuniv is also increasingly prescribed as an adjunct therapy — meaning it's used alongside a stimulant to improve the stimulant's effectiveness and reduce some of its side effects. This dual-use pattern adds additional demand pressure.

What Makes Intuniv Different from Adderall in Terms of Supply?

The key structural difference is that Intuniv is not a controlled substance. Adderall, Vyvanse, Ritalin, and other stimulant ADHD medications are Schedule II controlled substances, meaning the DEA caps how much can be manufactured each year. When patient demand outpaces those production quotas, a true national shortage occurs.

Intuniv faces no such DEA quota. Manufacturers can produce as much as the market demands, subject only to normal pharmaceutical manufacturing constraints. This is why Intuniv is widely recommended as a more supply-stable option for ADHD treatment — at least from a regulatory standpoint.

What Strengths and Forms of Guanfacine ER Are Available?

Intuniv is available as extended-release (ER) oral tablets in four strengths:

• 1 mg
• 2 mg
• 3 mg
• 4 mg

The immediate-release (IR) form of guanfacine is called Tenex and is used primarily for hypertension in adults and older children — it is not interchangeable with Intuniv on a milligram-per-milligram basis due to different pharmacokinetics. Always verify with your provider and pharmacist before considering any switch between IR and ER formulations.

What Should You Do If Your Pharmacy Is Out of Intuniv?

Here are practical steps to take right now:

1. Call multiple pharmacies. Ask specifically for the strength and form (generic guanfacine ER, or brand Intuniv) you need. Independent pharmacies often stock different inventory than chains like CVS, Walgreens, or Rite Aid.
2. Ask your pharmacist about alternative generics. Multiple manufacturers make guanfacine ER. If your insurance will cover a different generic, your pharmacist may be able to order it.
3. Use medfinder. medfinder calls pharmacies near you to check which ones have your medication in stock — so you don't have to spend hours on the phone yourself.
4. Talk to your prescriber. If Intuniv is consistently hard to find, your doctor may be able to suggest a comparable alternative or a different dosing approach. Never stop taking guanfacine abruptly — always taper under medical guidance.
5. Try mail-order pharmacy. Many insurance plans offer 90-day mail-order fills, which can bypass local stock issues entirely.

A Note on Stopping Intuniv

Unlike stimulant medications, which can generally be paused without risk of withdrawal symptoms, Intuniv should never be stopped abruptly. Guanfacine affects blood pressure and heart rate. Sudden discontinuation can cause rebound hypertension (a significant increase in blood pressure) and increased heart rate. If you cannot get a refill in time, contact your prescriber immediately so they can guide a safe taper or provide an emergency bridge supply.

Bottom Line

Intuniv is not in a formal U.S. shortage as of 2026, but localized stock gaps are real and frustrating. The good news is that practical steps — calling around, using discount pharmacies, and tools like medfinder — can usually resolve the issue quickly. For more help, see our guides on how to find Intuniv in stock near you and the Intuniv shortage update for 2026.